Literature DB >> 17380279

Histological study of gallbladder and bile duct epithelia in patients with anomalous arrangement of the pancreaticobiliary ductal system: comparison between those with and without a dilated common bile duct.

Yutaka Noda1, Naotaka Fujita, Go Kobayashi, Kei Ito, Jun Horaguchi, Osamu Takasawa, Takashi Obana, Kazuhiko Ishida, Shigeharu Senoo, Makoto Yonechi, Takashi Suzuki, Dai Hirasawa, Toshiki Sugawara, Masao Kobari, Takashi Sawai, Miwa Uzuki, Mika Watanabe.   

Abstract

BACKGROUND: We histologically evaluated the epithelia of the gallbladder (GB) and bile duct (BD) in patients with anomalous arrangement of the pancreaticobiliary ductal system (AAPB), with regard to the shape of the common BD (CBD).
METHODS: The GB and BD were studied histologically using surgical materials from 44 patients with AAPB: 27 with a dilated CBD (D-type) and 17 with a nondilated CBD (N-type).
RESULTS: GB cancer and BD cancer were found in 11.1% and 3.7% of D-type and 17.6% and 0% of N-type respectively. Hyperplastic epithelium and atypical epithelium of the GB were frequently seen in both D-type (46%, 46%) and N-type (82%, 70%), while such epithelia of the BD were only seen in D-type (10%, 35%). The Ki67 labeling index of the nonneoplastic epithelium of the GB was high in both D-type (13.0%) and N-type (9.7%), though that of the BD was high in D-type (12.5%) but low in N-type (1.8%). The prevalences of pyloric gland metaplasia, intestinal metaplasia, and p53 protein overexpression of the nonneoplastic epithelium did not show any significant differences between D-type and N-type.
CONCLUSIONS: It is suggested that the BD epithelium of N-type probably has a lower potential for developing malignancy than that of D-type, while the GB epithelia of both D-type and N-type have a high potential for developing malignancy. This might support the selection of simple cholecystectomy as the treatment of choice in AAPB patients of N-type, although further investigation of the BD epithelium is required in a larger number of such patients.

Entities:  

Mesh:

Year:  2007        PMID: 17380279     DOI: 10.1007/s00535-006-1991-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.

Authors:  T Matsubara; T Funabiki; O Jinno; Y Sakurai; S Hasegawa; H Imazu; M Ochiai
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

2.  Surgical treatment for anomalous arrangement of the pancreaticobiliary duct with nondilatation of the common bile duct.

Authors:  Naomi Iwai; Shigehisa Fumino; Tomoki Tsuda; Shigeru Ono; Osamu Kimura; Eiichi Deguchi
Journal:  J Pediatr Surg       Date:  2004-12       Impact factor: 2.545

3.  Whether or not prophylactic excision of the extrahepatic bile duct is appropriate for patients with pancreaticobiliary maljunction without bile duct dilatation.

Authors:  T Kusano; T Takao; K Tachibana; Y Tanaka; M Kamachi; Y Ikematsu; Y Nishiwaki; H Kida; S Waki; M Uchimura; M Furukawa
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

4.  Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.

Authors:  H Hara; S Morita; T Ishibashi; S Sako; T Dohi; M Iwamoto; N Tanigawa
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

5.  Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.

Authors:  S Masuhara; K Kasuya; T Aoki; A Yoshimatsu; A Tsuchida; Y Koyanagi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

6.  Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation.

Authors:  T Funabiki; T Matsubara; M Ochiai; Y Marugami; Y Sakurai; S Hasegawa; H Imazu
Journal:  Keio J Med       Date:  1997-12

7.  Gallstones in gallbladder diseases.

Authors:  M Yamamoto; S Nakajo; E Tahara
Journal:  Acta Pathol Jpn       Date:  1989-09

8.  Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct.

Authors:  K Hanada; M Itoh; K Fujii; A Tsuchida; M Hirata; S Ishimaru; T Iwao; N Eguchi; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

9.  Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.

Authors:  S Tanno; T Obara; T Fujii; Y Mizukami; R Shudo; N Nishino; H Ura; A J Klein-Szanto; Y Kohgo
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

10.  Induction of extrahepatic biliary carcinoma by N-nitrosobis(2-oxopropyl)amine in hamsters given cholecystoduodenostomy with dissection of the common duct.

Authors:  Y Tajima; T Eto; T Tsunoda; T Tomioka; K Inoue; T Fukahori; T Kanematsu
Journal:  Jpn J Cancer Res       Date:  1994-08
View more
  8 in total

1.  Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction.

Authors:  Narongsak Rungsakulkij; Paisarn Boonsakan
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

3.  Amylase levels in bile in patients with a morphologically normal pancreaticobiliary ductal arrangement.

Authors:  Jun Horaguchi; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Kei Ito; Osamu Takasawa; Takashi Obana; Takuro Endo; Kazunari Nakahara; Kazuhiko Ishida; Makoto Yonechi; Dai Hirasawa; Takashi Suzuki; Toshiki Sugawara; Tetuya Ohhira; Kengo Onochi; Yoshihiro Harada
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

4.  Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case.

Authors:  Sae Murakami; Tetsuo Ajiki; Kimihiko Ueno; Hidehiro Sawa; Shinobu Tsuchida; Izuru Otsubo; Yuko Yoshida; Kenta Shinozaki; Taro Okazaki; Ippei Matsumoto; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2013-04-12       Impact factor: 2.549

5.  Imaging findings in 75 pediatric patients with pancreaticobiliary maljunction: a retrospective case study.

Authors:  Wan-liang Guo; Shun-gen Huang; Jian Wang; Mao Sheng; Lin Fang
Journal:  Pediatr Surg Int       Date:  2012-08-15       Impact factor: 1.827

6.  Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients.

Authors:  Shun-Gen Huang; Wan-Liang Guo; Jian Wang; Mao Sheng; Xing-Hao Lan; Lin Fang
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

7.  Synchronous primary gallbladder and pancreatic cancer associated with congenital biliary dilatation and pancreaticobiliary maljunction.

Authors:  Haruki Mori; Hiroya Iida; Hiromitsu Maehira; Naomi Kitamura; Tomoharu Shimizu; Masaji Tani
Journal:  Surg Case Rep       Date:  2017-11-02

8.  Reflux-Associated Cholecystopathy: Analysis of 76 Gallbladders From Patients With Supra-Oddi Union of the Pancreatic Duct and Common Bile Duct (Pancreatobiliary Maljunction) Elucidates a Specific Diagnostic Pattern of Mucosal Hyperplasia as a Prelude to Carcinoma.

Authors:  Takashi Muraki; Bahar Memis; Michelle D Reid; Takeshi Uehara; Tetsuya Ito; Osamu Hasebe; Shinji Okaniwa; Naoto Horigome; Takeshi Hisa; Pardeep Mittal; Alexa Freedman; Shishir Maithel; Juan M Sarmiento; Alyssa Krasinskas; Jill Koshiol; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2017-09       Impact factor: 6.394

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.